C4X Discovery Holdings PLC (C4XD)

London
24.25
-0.50(-2.04%)
  • Volume:
    10,500
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    24.00 - 24.00

C4XD Overview

Prev. Close
24.5
Day's Range
24-24
Revenue
5.71M
Open
24
52 wk Range
23-47.9
EPS
-0.02
Volume
10,500
Market Cap
53.94M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
218,911
P/E Ratio
-
Beta
0.07
1-Year Change
-30.99%
Shares Outstanding
229,231,972
Next Earnings Date
28 Jun 2022
What is your sentiment on C4X Discovery Holdings PLC?
or
Market is currently closed. Voting is open during market hours.

C4X Discovery Holdings PLC Company Profile

C4X Discovery Holdings PLC Company Profile

C4X Discovery Holdings PLC is a United Kingdom-based company, which is engaged in the research and development through the identification, assessment and validation of Drug Discovery targets. The Company operates by early commercial partnering or initiation of a its drug discovery program to develop a small molecule. The Company also works in collaboration with partners. The Company has a portfolio ranging from early stage-target to late-stage drug discovery program ready for out-licensing to partners. The Company’s portfolio of pre-clinical small molecule candidates includes Oral NRF2 activator, Oral MALT1 inhibitor, Oral α4β7 integrin inhibitor, Oral Orexin-1 Antagonist (C4X_3256/INDV-2000), Oral IL-17A Inhibitor. It has developed activators of the NRF2 pathway for the treatment of a variety of inflammatory diseases including Inflammatory Bowel Disease (IBD), Sickle Cell Disease (SCD), Pulmonary Arterial Hypertension (PAH) and Chronic Obstructive Pulmonary Disorder (COPD).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell